Wei-Hsin Chen
Papers
1
Total Citations
6
H-Index
1
About
Dr. Wei-Hsin Chen is a urologic oncologist whose research focuses on advancing surgical outcomes for high-risk prostate cancer patients. His most cited work, a 2023 study on robot-assisted radical prostatectomy (RaRP), investigates oncological and functional results in patients classified as high-risk and very high-risk. By analyzing data from 100 localized prostate cancer patients who underwent RaRP between 2015 and 2020, Dr. Chen’s research provides critical insights into the feasibility and safety of robotic surgery in this challenging population. His contributions help refine treatment strategies, demonstrating that RaRP can achieve favorable cancer control while preserving urinary and sexual function, even in aggressive disease. With 6 citations to date, this study is gaining traction among clinicians seeking evidence-based approaches to managing high-risk prostate cancer. Dr. Chen’s work bridges the gap between surgical innovation and patient-centered outcomes, offering hope for improved quality of life without compromising oncological efficacy. His dedication to urologic oncology continues to shape best practices in robotic surgery, making him a valuable voice in the field.
Research Focus
Key Achievements
Top Papers
- 1